Cargando…
Can Immune Suppression and Epigenome Regulation in Placenta Offer Novel Insights into Cancer Immune Evasion and Immunotherapy Resistance?
Cancer is the second leading cause of mortality and morbidity in the developed world. Cancer progression involves genetic and epigenetic alterations, accompanied by aggressive changes, such as increased immune evasion, onset of metastasis, and drug resistance. Similar to cancer, DNA hypomethylation,...
Autores principales: | Hossain, Sultana Mehbuba, Lynch-Sutherland, Chiemi F., Chatterjee, Aniruddha, Macaulay, Erin C., Eccles, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594685/ https://www.ncbi.nlm.nih.gov/pubmed/34968365 http://dx.doi.org/10.3390/epigenomes5030016 |
Ejemplares similares
-
Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance
por: Hossain, Sultana Mehbuba, et al.
Publicado: (2023) -
Reawakening the Developmental Origins of Cancer Through Transposable Elements
por: Lynch-Sutherland, Chiemi F., et al.
Publicado: (2020) -
DNA methylation and epigenomics: new technologies and emerging concepts
por: Chatterjee, Aniruddha, et al.
Publicado: (2015) -
Immunotherapy and Immune Evasion in Prostate Cancer
por: Thakur, Archana, et al.
Publicado: (2013) -
Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures
por: Hossain, Sultana Mehbuba, et al.
Publicado: (2022)